Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.

NCT00750360 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
883
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline